Todd Brown, MD, PhD







  •     Member, Bone Complications Working Group of the Inflammation TSG 08/19/08-Present
  •     Member, Immune Activation Focus Group of Inflammation TSG, 04/01/14-Present
  •     Member, Inflammation TSG
  •     Member, Exercise Focus Group of the Inflammation TSG, 03/25/14-Present
  •     Protocol Co-Chair, ACTG 5260s, ACTG 5318 (LEACH)
  •     Protocol Vice-Chair, ACTG 5280, ACTG 5303
  •     Co-chair, ACTG 5361s
  •     Co-investigator, ACTG 5257


Leadership Committees

Clinical Trials

A5324: A Randomized, Double-Blinded, Placebo-Controlled...

ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...

Read More

P1078: A Phase IV Randomized Double-Blind Placebo-Controlled...

P1078 is a Phase IV, randomized, double-blind, placebo-controlled study of HIV-infected pregnant women and the infants born to...

Read More

A5274: REMEMBER, Reducing Early Mortality and Early...

This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...

Read More

A5300/P2003: PHOENIx Feasibility Study

Study of MDR TB Cases and Their Household Contacts: Operational Feasibility to Inform PHOENIx Trial Design

Read More

A5327: Sofosbuvir + Ribavirin w/o Interferon for Treatment...

A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...

Read More